Differences in the expression levels of sars-cov-2 spike protein in cells treated with mrna-based covid-19 vaccines: a study on vaccines from the real world

HIGHLIGHTS

• who: Luigi Cari and collaborators from the University of Perugia, Perugia, Italy have published the paper: Differences in the Expression Levels of SARS-CoV-2 Spike Protein in Cells Treated with mRNA-Based COVID-19 Vaccines: A Study on Vaccines from the Real World, in the Journal: Vaccines 2023, 11, 879. of /2023/
• what: In Antibody_Response and Adverse Events between Comirnaty and Spikevax Spikevax Vaccines Vaccines the study demonstrates higher S-protein expression levels in cells treated with Spike- the studywith demonstrates S-protein expression levels in cellsboth treated with vax compared Comirnatyhigher following an . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.